home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

DIA/FDA Quantitative Structure-activity Relationship (Q)SAR Approaches to Assessing Genotoxic Impurities in Pharmaceuticals Maria Susan Mazak

 
  December 01, 2010  
     
 
Hilton Rockville Hotel , Rockville, MD, USA
Apr 7 2011 8:00AM - 5:00PM


How to Use (Q)SAR to Assess Impurities for Potential Genotoxicity.

Join industry scientists and regulators addressing what constitutes an acceptable in silico evaluation and how to incorporate public and proprietary sources of data into an integrated assessment. The timing of this particular workshop will provide critical input on the discussions for the June 2011 meeting for ICH M7 (Mutagenic Impurities).

FEATURED TOPICS
• Computational assessment using (Q)SAR to predict the outcome of Ames for potential genotoxic impurities
• Criteria needed to assess the adequacy of databases for confidence in a negative outcome
• Addressing conflicting outputs from (Q)SAR
• Adding weight-of-evidence to (Q)SAR assessments; the role of literature, scientific judgment and proprietary data
• Understanding similarity in chemical space; how experimental evidence of the API can aid the assessment of potential genotoxic impurities


Event Code:
11015
 
 
Organized by: DIA
Invited Speakers: Call contact
 
Deadline for Abstracts: Call contact
 
Registration:
Contact Constance Burnett at the DIA office by telephone 215.293.5800, fax 215.442.6199 or email Constance.Burnett@diahome.org.
 
 


E-mail: Constance.Burnett@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.